Cambridge Cognition Holdings Plc (COG.L)

48,50 0,00 (0,00%) Al cierre: 03:29PM BST

Cambridge Cognition Holdings Plc

Tunbridge Court
Tunbridge Lane Bottisham
Cambridge CB25 9TU
United Kingdom
44 1223 810 700
https://www.cambridgecognition.com

Sector(es): Healthcare
Sector: Health Information Services
Empleados a tiempo completo: 80

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Dr. Matthew William Stork	CEO & Director	342k	N/A	1968
Mr. John Hammond	Co-Founder	N/A	N/A	N/A
Mr. Nick Taptiklis	Head of Technology Strategy	N/A	N/A	N/A
Ms. Francesca Cormack Ph.D.	Chief Scientist & Member of Scientific Advisory Board	N/A	N/A	N/A
Mr. Simon Merritt	Marketing and Communications Director	N/A	N/A	N/A
Dr. Lisa Elizabeth Nolan Ph.D.	Vice President Business Development	N/A	N/A	1962
Ms. Nicky Ackerley	Global HR Director	N/A	N/A	N/A
Prof. Trevor Robbins CBE, FBPsS, FMedSci, FRS, Ph.D.	Senior Consultant	N/A	N/A	N/A
Prof. Barbara Sahakian FBPsS, FMedSci	Senior Consultant	N/A	N/A	N/A

Los importes son a partir de 31 de diciembre de 2022 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en GBp.

Descripción

Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval, as well as supports sponsors to enhance recruitment, develop safe and effective treatments, and enhance research and development efficiency. It also provides CANTAB Connect Research, a proprietary platform that provides insights into behaviours, underlying brain circuits, and measurement of digital cognitive biomarkers; CANTAB Mobile, a touchscreen assessment of memory, mood, and functional status to detect the earliest signs of clinically relevant memory problems; CANTAB Insight to assess cognitive health; and CANTAB BrainHealth for assessing workplace wellbeing. In addition, the company offers electronic questionnaires and scales, a digital bespoke questionnaire; NeuroVocalix, a voice analysis platform to analyze voice to assess neurological change; cognition kit, a high frequency testing kit to detect changes over time and day-to-day cognition with short regular tests using patients' own devices. Cambridge Cognition Holdings Plc was incorporated in 2012 and is based in Cambridge, the United Kingdom.

Gobierno corporativo

El ISS Governance QualityScore de Cambridge Cognition Holdings Plc, a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.